Show simple item record

dc.contributor.authorUgarte-Gil, M.F.
dc.contributor.authorAlarcón, G.S.
dc.date.accessioned2025-10-31T18:32:27Z
dc.date.available2025-10-31T18:32:27Z
dc.date.issued2016
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4652
dc.description.abstractWe read with great interest the article published recently in Arthritis Care & Research by Costenbader and Schur, and with this editorial we would like to offer additionaal insights and views. While we fully agree with the fact that autoimmunity does not occur overnight, that autoantibodies may be present years before any clinical manifestation of lupus ensues, and that in lupus disease manifestations may evolve over a variable time period (days to years), we also think that in the clinical setting we must be exceedingly careful about the name we give to those individuals who eventually may (or may not) evolve into a defined systemic lupus erythematosus (SLE) phenotype...en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherJohn Wiley and Sons
dc.relation.ispartofurn:issn:2151-464X
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSystemic Lupus Erythematosus and Patient Outcomesen_US
dc.subjectSystemic Lupus Erythematosus Impact and Managementen_US
dc.titleIncomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?en_US
dc.typehttps://purl.org/coar/resource_type/c_b239
dc.identifier.doihttps://doi.org/10.1002/acr.22663
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#5.00.00
dc.type.otherEditorial
dc.identifier.journalArthritis Care and Research
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2